Carlos V. Paya - Nov 9, 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
Carlos V. Paya, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Nov 9, 2023
Transactions value $
$0
Form type
4
Date filed
11/9/2023, 04:36 PM
Previous filing
Jun 16, 2023
Next filing
Jun 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Gift $0 -3.13K -55.56% $0.00 2.5K Nov 9, 2023 Direct F1, F2
transaction PCVX Common Stock Award $0 +3.13K $0.00 3.13K Nov 9, 2023 By Family Trust F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Gift $0 -30K -100% $0.00* 0 Nov 9, 2023 Common Stock 30K $22.02 Direct F1, F4
transaction PCVX Stock Option (right to buy) Gift $0 +30K $0.00 30K Nov 9, 2023 Common Stock 30K $22.02 By Family Trust F1, F4, F5
transaction PCVX Stock Option (right to buy) Gift $0 -18.8K -100% $0.00* 0 Nov 9, 2023 Common Stock 18.8K $22.70 Direct F1, F6
transaction PCVX Stock Option (right to buy) Gift $0 +18.8K $0.00 18.8K Nov 9, 2023 Common Stock 18.8K $22.70 By Family Trust F1, F5, F6
transaction PCVX Stock Option (right to buy) Gift $0 -15K -100% $0.00* 0 Nov 9, 2023 Common Stock 15K $53.08 Direct F1, F7
transaction PCVX Stock Option (right to buy) Gift $0 +15K $0.00 15K Nov 9, 2023 Common Stock 15K $53.08 By Family Trust F1, F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions involve the Reporting Person's transfer of certain securities to a trust for the sole benefit of the Reporting Person.
F2 As previously disclosed in Reporting Person's Form 4 filed on June 15, 2023, this represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
F3 Shares are held directly by a trust for the sole benefit of the Reporting Person.
F4 Option vests over 36 months, 1/3 of which will vest on October 27, 2022 and 1/36 of which will vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date.
F5 Options are held directly by a trust for the sole benefit of the Reporting Person.
F6 The shares of Common Stock subject to the option vested fully on June 1, 2023.
F7 The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 13, 2024 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.